Long-term efficacy and safety of SARS-CoV-2 vaccination in patients with chronic kidney disease, on dialysis or after kidney transplantation: a national prospective observational cohort study

被引：0
作者：
P. Bouwmans
A. L. Messchendorp
J. S. Sanders
L. Hilbrands
M. E. J. Reinders
P. Vart
F. J. Bemelman
A. C. Abrahams
M. A. van den Dorpel
M. A. Ten Dam
A. P. J. de Vries
T. Rispens
M. Steenhuis
R. T. Gansevoort
M. H. Hemmelder
机构：
[1] Maastricht University Medical Center,Department of Internal Medicine, Division of Nephrology
[2] University of Maastricht,CARIM school for cardiovascular disease
[3] University Medical Center Groningen,Department of Nephrology
[4] University of Groningen,Department of Nephrology
[5] Radboud University Medical Center,Internal Medicine, Nephrology and Transplantation
[6] Erasmus MC Transplant Institute,Department of Internal Medicine
[7] Erasmus Medical Center,Department of Clinical Pharmacy and Pharmacology
[8] University Medical Center Groningen,Department of Internal Medicine, Division of Nephrology
[9] University Medical Center Groningen,Department of Nephrology and Hypertension
[10] Amsterdam University Medical Center – location Amsterdam Medical Center,Department of Nephrology
[11] University Medical Center Utrecht,Department of Internal Medicine
[12] Maasstad Hospital,Department of Medicine, Division of Nephrology, and Leiden Transplant Center
[13] Canisius Wilhelmina Hospital,Landsteiner Laboratory
[14] Leiden University Medical Center,undefined
[15] Department of Immunopathology,undefined
[16] Sanquin Research,undefined
[17] Amsterdam University Medical Center,undefined
[18] University of Amsterdam,undefined
来源：
BMC Nephrology | / 23卷
关键词：
SARS-CoV-2; Vaccine; Chronic kidney disease; Kidney transplantation; Dialysis; Safety; Efficacy; Antibody response;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 51 条
[1]  
Williamson EJ(2020)Factors associated with COVID-19-related death using OpenSAFELY Nature. 584 430-436
[2]  
Walker AJ(2020)CKD is a key risk factor for COVID-19 mortality Nat Rev Nephrol 16 705-706
[3]  
Bhaskaran K(2020)COVID-19-related mortality in kidney transplant and dialysis patients: results of the ERACODA collaboration Nephrol Dial Transplant 35 1973-1983
[4]  
Bacon S(2020)Results from the ERA-EDTA Registry indicate a high mortality due to COVID-19 in dialysis patients and kidney transplant recipients across Europe Kidney Int 98 1540-1548
[5]  
Bates C(2021)Efficacy and Safety of the mRNA-1273 SARS-CoV-2 Vaccine N Engl J Med 384 403-416
[6]  
Morton CE(2020)Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine N Engl J Med 383 2603-2615
[7]  
Gansevoort RT(2021)Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK Lancet. 397 99-111
[8]  
Hilbrands LB(2019)Vaccination in Chronic Kidney Disease Adv Chronic Kidney Dis 26 72-78
[9]  
Hilbrands LB(2020)Development of a SARS-CoV-2 Total Antibody Assay and the Dynamics of Antibody Response over Time in Hospitalized and Nonhospitalized Patients with COVID-19 J Immunol 205 3491-3499
[10]  
Duivenvoorden R(2021)What defines an efficacious COVID-19 vaccine? A review of the challenges assessing the clinical efficacy of vaccines against SARS-CoV-2 Lancet Infect Dis 21 e26-e35
123456